Hao Cui, Hartzell V. Schaff, Juliano Lentz Carvalho, Rick A. Nishimura, ... Joseph J. Maleszewski
doi : 10.1016/j.jacc.2021.03.008
Volume 77, Issue 17, 4 May 2021, Pages 2159-2170
Hypertrophic cardiomyopathy (HCM) is characterized by multiple pathological features including myocyte hypertrophy, myocyte disarray, and interstitial fibrosis.
Ethan J. Rowin, Michael A. Fifer
doi : 10.1016/j.jacc.2021.03.292
Volume 77, Issue 17, 4 May 2021, Pages 2171-2173
Emily M. Garland, Alfredo Gamboa, Victor C. Nwazue, Jorge E. Celedonio, ... Satish R. Raj
doi : 10.1016/j.jacc.2021.03.005
Volume 77, Issue 17, 4 May 2021, Pages 2174-2184
High sodium intake is recommended for the treatment of postural tachycardia syndrome (POTS) to counteract the hypovolemia and elevated plasma norepinephrine that contribute to excessive orthostatic tachycardia, but evidence of its efficacy is not available.
Blair P. Grubb
doi : 10.1016/j.jacc.2021.03.229
Volume 77, Issue 17, 4 May 2021, Pages 2185-2186
Laurent Faroux, Thibault Lhermusier, Flavien Vincent, Luis Nombela-Franco, ... Josep Rodés-Cabau
doi : 10.1016/j.jacc.2021.03.014
Volume 77, Issue 17, 4 May 2021, Pages 2187-2199
Among patients with acute coronary syndrome following transcatheter aortic valve replacement (TAVR), those presenting with ST-segment elevation myocardial infarction (STEMI) are at highest risk.
Luis Gruberg, Puneet Gandotra
doi : 10.1016/j.jacc.2021.03.300
Volume 77, Issue 17, 4 May 2021, Pages 2200-2203
Hans-Josef Feistritzer, Thomas Kurz, Georg Stachel, Philipp Hartung, ... Holger Thiele
doi : 10.1016/j.jacc.2021.03.007
Volume 77, Issue 17, 4 May 2021, Pages 2204-2215
The randomized SOLVE-TAVI (compariSon of secOnd-generation seLf-expandable vs. balloon-expandable Valves and gEneral vs. local anesthesia in Transcatheter Aortic Valve Implantation) trial compared newer-generation self-expanding valves (SEV) and balloon-expandable valves (BEV) as well as local anesthesia with conscious sedation (CS) and general anesthesia (GA) in patients undergoing transfemoral transcatheter aortic valve replacement (TAVR). Both strategies showed similar outcomes at 30 days.
Samir R. Kapadia, Amar Krishnaswamy
doi : 10.1016/j.jacc.2021.03.294
Volume 77, Issue 17, 4 May 2021, Pages 2216-2218
Gerhard-Paul Diller, Alexandra Arvanitaki, Alexander R. Opotowsky, Kathy Jenkins, ... Ariane Marelli
doi : 10.1016/j.jacc.2021.03.012
Volume 77, Issue 17, 4 May 2021, Pages 2219-2235
More than 90% of patients with congenital heart disease (CHD) are nowadays surviving to adulthood and adults account for over two-thirds of the contemporary CHD population in Western countries.
Mattia Vinciguerra, Cristiano Spadaccio, Charlene Tennyson, Mukesh Karuppannan, ... David Rose
doi : 10.1016/j.jacc.2021.03.009
Volume 77, Issue 17, 4 May 2021, Pages 2236-2253
Saphenous vein graft aneurysms (SVGAs) following coronary artery bypass grafting (CABG) surgery were first described in 1975. Although rare, in the absence of a prompt diagnosis, SVGAs can be responsible for serious complications and adverse outcomes. The clinical presentation of SVGAs described in the literature can vary from an asymptomatic patient with an incidental radiological finding to a profoundly shocked patient with life-threatening hemorrhage secondary to SVGA rupture.
Michael J. Zhang
doi : 10.1016/j.jacc.2021.02.061
Volume 77, Issue 17, 4 May 2021, Pages 2254-2257
William E. Boden
doi : 10.1016/j.jacc.2021.02.064
Volume 77, Issue 17, 4 May 2021, Pages 2256-2257
Joshua Lampert, Michael Miller, Jonathan L. Halperin, Connor Oates, ... Vivek Y. Reddy
doi : 10.1016/j.jacc.2021.02.062
Volume 77, Issue 17, 4 May 2021, Pages 2258-2259
Jesus Alvarez-Garcia, Suraj Jaladanki, Mercedes Rivas-Lasarte, Matthew Cagliostro, ... Anuradha Lala
doi : 10.1016/j.jacc.2021.03.006
Volume 77, Issue 17, 4 May 2021, Pages 2260-2262
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟